FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Volume: 364, Issue: 19, Pages: 1817 - 1825
Published: May 12, 2011
Abstract
Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic...
Paper Details
Title
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Published Date
May 12, 2011
Volume
364
Issue
19
Pages
1817 - 1825
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History